English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/149149
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Ischemic brain injury: New insights on the protective role of melatonin

AuthorsRamos, Eva; Patiño, Paloma; Reiter, Russel J.; Gil-Martín, Emilio; Marco-Contelles, José ; Parada, Esther; Ríos, Cristobal de los; Romero, Alejandro ; Egea, Javier
KeywordsFree radicals
Brain ischemia
Issue Date2017
CitationFree Radical Biology and Medicine 104: 32- 53 (2017)
AbstractStroke represents one of the most common causes of brain's vulnerability for many millions of people worldwide. The plethora of physiopathological events associated with brain ischemia are regulate through multiple signaling pathways leading to the activation of oxidative stress process, Ca dyshomeostasis, mitochondrial dysfunction, proinflammatory mediators, excitotoxicity and/or programmed neuronal cell death. Understanding this cascade of molecular events is mandatory in order to develop new therapeutic strategies for stroke. In this review article, we have highlighted the pleiotropic effects of melatonin to counteract the multiple processes of the ischemic cascade. Additionally, experimental evidence supports its actions to ameliorate ischemic long-term behavioural and neuronal deficits, preserving the functional integrity of the blood-brain barrier, inducing neurogenesis and cell proliferation through receptor-dependent mechanism, as well as improving synaptic transmission. Consequently, the synthesis of melatonin derivatives designed as new multitarget-directed products has focused a great interest in this area. This latter has been reinforced by the low cost of melatonin and its reduced toxicity. Furthermore, its spectrum of usages seems to be wide and with the potential for improving human health. Nevertheless, the molecular and cellular mechanisms underlying melatonin¿s actions need to be further exploration and accordingly, new clinical studies should be conducted in human patients with ischemic brain pathologies.
Publisher version (URL)http://dx.doi.org/10.1016/j.freeradbiomed.2017.01.005
Identifiersdoi: 10.1016/j.freeradbiomed.2017.01.005
issn: 0891-5849
e-issn: 1873-4596
Appears in Collections:(IQOG) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.